Legislature(2015 - 2016)BARNES 124
04/11/2016 03:15 PM LABOR & COMMERCE
Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
Download Mp3. <- Right click and save file as
Download Video part 1. <- Right click and save file as
|Alaska Workers' Compensation Board|
* first hearing in first committee of referral
= bill was previously heard/scheduled
= bill was previously heard/scheduled
SB 142-INSURANCE FOR ANTI-CANCER MEDICATION [Due to technical difficulties, the record from 4:49:46 p.m. to 4:51:39 p.m. was reconstructed from the recording secretary's log notes.] 4:49:46 PM CHAIR OLSON announced that the final order of business would be CS FOR SENATE BILL NO. 142(L&C) am, "An Act relating to insurance coverage for anti-cancer medications." [During the meeting of 4/6/16, Amendment 1, labeled 29- LS1133\W.A.1, Wallace, 4/5/16, was objected to by Representative LeDoux. Amendment 1 read: Page 1, line 1, following "medications": Insert "; and providing for an effective date" Page 2, following line 14: Insert a new bill section to read: "* Sec. 3. This Act takes effect January 1, 2017."] [Chair Olson stated that he objected to Amendment 1 at the previous hearing.] REPRESENTATIVE JOSEPHSON asked Ms. Wing-Heier to elaborate on her previous testimony regarding an individual's choice of a pharmacy. 4:51:51 PM LORI WING-HEIER, Director, Division of Insurance, Department of Commerce, Community & Economic Development (DCCED), explained that if an individual goes to a pharmacy [out-of-network] they will receive a higher copay, which is how the plans are written within the individual's plan. REPRESENTATIVE JOSEPHSON observed that an individual may choose to go to an alternate pharmacy but would risk paying more. MS. WING-HEIER agreed and stated that if the individual chooses to go to a pharmacy out-of-network, just as they may choose to go to a physician out-of-network, there would be a higher copay. REPRESENTATIVE JOSEPHSON referred to the effective date of the bill, and recalled testimony regarding the urgency of the application if the bill becomes law, such as administrative problems associated with the bill. He asked for clarification of the effective date shown on page 2, line 12. MS. WING-HEIER explained that the division must comply with the effective date of the [Patient Protection and Affordable Care Act of 2010 (PPACA)], and most of the plans now are dated January 1. Therefore, the form filings and such have to be May 11, although they can be amended up until mid-August, but the first form filings are due for the 2017 plans on May 11. The division is beginning to receive form filings that are affected by this and other pending bills, thus the division is "squeezed into this 30-day period for bills that haven't passed, to be signed, to go to the insurers, to be [put] into plan documents, to be filed with ... the division, to be approved, and that's the, the administrative heartache that we're asking for a revised effective date." 4:53:50 PM CHAIR OLSON removed his objection to Amendment 1 [and the committee treated the objection made by Representative LeDoux as withdrawn.] There being no further objection, Amendment 1 was adopted. CHAIR OLSON opened public testimony and after ascertaining no one wished to testify, closed public testimony. 4:54:34 PM REPRESENTATIVE TILTON moved to report the committee substitute for CSSB 142(L&C)am, Version 29-LS1133\W.A, as amended, out of committee with individual recommendations and the accompanying zero fiscal notes. There being no objection, HCS CSSB 142(L&C) was reported out of the House Labor and Commerce Standing Committee.